These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24459790)

  • 1. Compatibility of amiodarone hydrochloride with vasopressin during simulated Y-site administration.
    Ramaley CC; Li F; Du C
    Int J Pharm Compd; 2013; 17(5):436-8. PubMed ID: 24459790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability and compatibility of fluorouracil and mannitol during simulated Y-site administration.
    Woloschuk DM; Wermeling JR; Pruemer JM
    Am J Hosp Pharm; 1991 Oct; 48(10):2158-60. PubMed ID: 1781472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermal behavior study and decomposition kinetics of amiodarone hydrochloride under isothermal conditions.
    Yoshida MI; Gomes EC; Soares CD; Oliveira MA
    Drug Dev Ind Pharm; 2011 Jun; 37(6):638-47. PubMed ID: 21449701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical compatibility of cefmetazole sodium with ranitidine hydrochloride during simulated Y-site administration.
    Inagaki K; Gill MA; Okamoto MP; Takagi J
    J Parenter Sci Technol; 1993; 47(1):35-9. PubMed ID: 8445498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incompatibility of amiodarone hydrochloride and evacuated glass bottles.
    Strozyk WR; Williamson R; Thompson D
    Am J Health Syst Pharm; 1996 Jan; 53(2):184. PubMed ID: 8653486
    [No Abstract]   [Full Text] [Related]  

  • 6. Stability of amiodarone hydrochloride in admixtures with other injectable drugs.
    Campbell S; Nolan PE; Bliss M; Wood R; Mayersohn M
    Am J Hosp Pharm; 1986 Apr; 43(4):917-21. PubMed ID: 3706337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual compatibility of amiodarone hydrochloride injection with various intravenous drugs.
    Chalmers JR; Bobek MB; Militello MA
    Am J Health Syst Pharm; 2001 Mar; 58(6):504-6. PubMed ID: 11286148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability study of amiodarone hydrochloride in capsules for paediatric patients using a high-performance liquid chromatography method.
    Rughoo L; Vigneron J; Zenier H; May I; Demoré B
    Ann Pharm Fr; 2012 Mar; 70(2):88-93. PubMed ID: 22500960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Physical compatibility of amiodarone in continuous infusion].
    Maqueda-Palau M; Pérez-Juan E; Arévalo-Rubert MJ; Amorós-Cerdá SM; Ribas-Nicolau B
    Enferm Clin; 2011; 21(1):25-9. PubMed ID: 20705496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration.
    Trissel LA; Gilbert DL; Martinez JF
    Am J Health Syst Pharm; 1997 Jan; 54(1):56-60. PubMed ID: 9117791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compatibility of esmolol hydrochloride with morphine sulfate and fentanyl citrate during simulated Y-site administration.
    Karnatz NN; Wong J; Kesler H; Baaske DM; Speicher ER
    Am J Hosp Pharm; 1988 Feb; 45(2):368-71. PubMed ID: 2896460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration.
    Asempa TE; Avery LM; Kidd JM; Kuti JL; Nicolau DP
    Am J Health Syst Pharm; 2018 Jul; 75(14):1048-1056. PubMed ID: 29895521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
    Trissel LA; Williams KY; Gilbert DL
    J Am Pharm Assoc (Wash); 2000; 40(4):515-9. PubMed ID: 10932461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability and compatibility of tirofiban hydrochloride during simulated Y-site administration with other drugs.
    Bergquist PA; Manas D; Hunke WA; Reed RA
    Am J Health Syst Pharm; 2001 Jul; 58(13):1218-23. PubMed ID: 11449879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicochemical Compatibility of Amiodarone with Parenteral Nutrition.
    Mediavilla MM; Molina A; Navarro L; Grau L; Pujol MD; Cardenete J; Cardona D; Riera P
    JPEN J Parenter Enteral Nutr; 2019 Feb; 43(2):298-304. PubMed ID: 29992576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compatibility and stability of ondansetron hydrochloride, dexamethasone, and lorazepam in injectable solutions.
    McGuire TR; Narducci WA; Fox JL
    Am J Hosp Pharm; 1993 Jul; 50(7):1410-4. PubMed ID: 8362872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Stability of amiodarone hydrochloride in intravenous fluids with 5% glucose].
    Simar G; Detcave C; Godet M; Decoster C; Gillet P; Bihin B; Jamart J; GaLanti LM; Hecq JD
    J Pharm Belg; 2016 Mar; (1):24-25. PubMed ID: 30281220
    [No Abstract]   [Full Text] [Related]  

  • 18. Stability and compatibility of lidocaine hydrochloride with selected large-volume parenterals and drug additives.
    Kirschenbaum HL; Aronoff W; Perentesis GP; Plitz GW; Cutie AJ
    Am J Hosp Pharm; 1982 Jun; 39(6):1013-5. PubMed ID: 7102682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compatibility of verapamil hydrochloride with penicillin admixtures during simulated Y-site injection.
    Thompson DF; Stiles ML; Allen LV; Tu YH
    Am J Hosp Pharm; 1988 Jan; 45(1):142-5. PubMed ID: 3348228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of ranitidine hydrochloride with aztreonam, ceftazidime, or piperacillin sodium during simulated Y-site administration.
    Inagaki K; Gill MA; Okamoto MP; Takagi J
    Am J Hosp Pharm; 1992 Nov; 49(11):2769-72. PubMed ID: 1471644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.